Gilead Sciences

Remdesivir therapy, an experimental antiviral therapy that has been used to treat COVID-19, has no substantial effect on a patient’s chances of survival.

BERLIN—Gilead Sciences Inc plans to make more of its drug remdesivir available for Germany and Europe from autumn ...

A California-based company is charging hundreds of dollars per vial for a drug it created that's shown promise ...

An experimental drug recently touted for its effectiveness against COVID-19 showed a limited benefit for more moderately ill ...

The antiviral drug remdesivir sped up recovery from COVID-19, but researchers said the drug requires a supplement and ...

Gilead Sciences on Wednesday said it was aware of "positive data" from a study on remdesivir's effectiveness against ...

An antiviral drug tested against COVID-19 in patients in China did not quicken their improvement or prevent death, ...

Treatments for the new coronavirus could be ready in months, pharmaceutical executives told President Donald Trump at the ...

Gilead Sciences Inc. announced this week that it will start two studies to evaluate a drug as a ...

Researchers in the United States started a clinical trial of the Gilead Sciences drug remdesivir to evaluate it ...